It would not be simple to adapt the QFT technology to PON (or POC) tests because you have to carry out the 20 hour or longer incubation to get the IFN gamma released from the T cells.
I guess you could continue to do this In Tube and then quantify the IFN by such a test but you would still have this delay - hence the main advantage of a PON test would be lost.
- Forums
- ASX - By Stock
- CST
- takeover
takeover, page-15
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.90M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13842 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.3¢ | 36144 | 1 |
Last trade - 11.02am 25/11/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online